We are live on
!
Find out more
LP
Lexington Partners Portfolio holdings
AUM
$134M
1-Year Est. Return
1.93%
This Fund
S&P 500
This Quarter
Est. Return
-5.14%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$140M
AUM Growth
-$12M
(-7.9%)
Cap. Flow
-$4.18M
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
5
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$2.02M |
| 2 |
QuantumScape Corp
QS
|
+$1.3M |
| 3 |
Sera Prognostics
SERA
|
+$391K |
| 4 |
Coinbase
COIN
|
+$269K |
| 5 |
LegalZoom.com
LZ
|
+$191K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 77.32% |
| 2 | Technology | 22.68% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
| 5 | Healthcare | 0% |
Similar funds
RA
SWM
SA
SA
GEH
BGI
MMCM
STFP
Lexington Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Lexington Partners held 9 positions worth $140M, down 7.9% from $152M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lexington Partners's Q1 2024 filing shows 5 closed positions. The largest sale was Mirum Pharmaceuticals, an estimated $2.02M.
By sector, the portfolio is most concentrated in Consumer Staples at 77% of assets, up from 76% a quarter earlier, followed by Technology and Consumer Discretionary.
- Lexington Partners fully exited Mirum Pharmaceuticals in Q1 2024, selling an estimated $2.02M.
- Lexington Partners's ten largest holdings make up 100% of its $140M portfolio in Q1 2024.
- Lexington Partners opened 0 new positions and closed 5 in Q1 2024.
- Lexington Partners's portfolio value fell 7.9% quarter-over-quarter to $140M.
Based on Lexington Partners's 13F filing for Q1 2024, filed 13 May 2024.